| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| C6000041288 |
|
— |
C-Reactive protein（CRP） - ＞95% |
0 | — | |
| C6000041287 |
|
— |
Human Lipocalin-2/NGAL - |
0 | — | |
| C6000041285 |
|
— |
Cyclic citrulline peptide - ＞90% |
0 | — | |
| C6000041284 |
|
— |
Hepatitis E virus（HEV） - ＞95% |
0 | — | |
| C6000041283 |
|
— |
Recombinant Hyaluronic acid binding protein（HABP） - ＞95% |
0 | — | |
| C6000041282 |
|
— |
Heart-type Fatty Acid Binding Protein - ＞95% |
0 | — | |
| C6000041281 |
|
— |
Procalcitonin（PCT） - ＞95% |
0 | — | |
| C6000041280 |
|
— |
Retinol Binding Protcin（RBP） - ＞95% |
0 | — | |
| C6000041279 |
|
— |
Immunoglobulin G（IgG） - ＞95% |
0 | — | |
| C6000041278 |
|
— |
Leptospira antigen - ＞90% |
0 | — | |
| C6000041277 |
|
100684-32-0 |
Myoglobin(MB) - ＞95% |
0 | — | |
| C6000041274 |
|
11006-33-0 |
Phleomycin - 98% |
0 | C55H86N20O21S2 | |
| C6000041273 |
|
1572943-04-4 |
Tezepelumab - 98% |
0 | — | |
| C6000041272 |
|
1260393-98-3 |
Lecanemab - 98% |
0 | — | |
| C6000041271 |
|
1044511-01-4 |
BENRALIZUMAB - 98% |
0 | — | |
| C6000041270 |
|
1384260-65-4 |
Aducanumab - 98% |
0 | — | |
| C6000041269 |
|
24939-03-5 |
Polyinosinic acid-polycytidylic acid (P I : C) - 90% |
0 | C19H27N7O16P2 | |
| C6000041261 |
|
152-62-5 |
Dydrogesterone - 98% |
0 | C21H28O2 | |
| C6000041260 |
|
41689-31-0 |
N-(2-Acetamido)iminodiacetic acid disodium salt - 98% |
0 | C6H11N2NaO5 | |
| C6000041259 |
|
2105-43-3 |
FursultiamineHydrochloride - 98% |
0 | C17H27ClN4O3S2 | |
